Norm Rosenthal

Evaluation of Bone Mineral Density and Bone Biomarkers in Patients With Type 2 Diabetes Treated With Canagliflozin

John P. Bilezikian, Nelson B. Watts, Keith Usiskin et al. · The Journal of Clinical Endocrinology & Metabolism · 2015 · 259 citations · Full text

Cardiovascular and Renal Outcomes With Canagliflozin According to Baseline Kidney Function

Brendon L. Neuen, Toshiaki Ohkuma, Bruce Neal et al. · Circulation · 2018 · 245 citations · Full text

Risk of lower extremity amputations in people with type 2 diabetes mellitus treated with sodium‐glucose co‐transporter‐2 inhibitors in the USA: A retrospective cohort study

Žhong Yuan, Frank DeFalco, Patrick Ryan et al. · Diabetes Obesity and Metabolism · 2017 · 118 citations · Full text

Optimizing the analysis strategy for the <scp>CANVAS</scp> Program: A prespecified plan for the integrated analyses of the <scp>CANVAS</scp> and <scp>CANVAS‐R</scp> trials

Bruce Neal, Vlado Perkovic, Kenneth W. Mahaffey et al. · Diabetes Obesity and Metabolism · 2017 · 100 citations · Full text

Analysis Strategy, Cardiovascular Pharmacology, Pharmacotherapy +22

Familial Neurological Disease Associated With Spongiform Encephalopathy

Norm Rosenthal, John Keesey, B F Crandall et al. · Archives of Neurology · 1976 · 75 citations

Creutzfeldt-jakob Disease, Neurological Disorder, Genetics +23